Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure

This publication has 22 references indexed in Scilit:

• Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 2003
• ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary
  Journal of the American College of Cardiology, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Effectiveness of Spironolactone Added to an Angiotensin-Converting Enzyme Inhibitor and a Loop Diuretic for Severe Chronic Congestive Heart Failure (The Randomized Aldactone Evaluation Study [RALES])**See Appendix for full list of RALES investigators.
  The American Journal of Cardiology, 1996
• Hyperkalaemia in diabetes: prevalence and associations
  Published by Oxford University Press (OUP) ,1995
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Hyperkalemia in diabetes mellitus
  Journal of Diabetic Complications, 1990
• Hyperkalemia in Diabetes Mellitus
  Archives of internal medicine (1960), 1989
• Severe Hyperkalemia as a Complication of Timolol, a Topically Applied ß-Adrenergic Antagonist
  Archives of internal medicine (1960), 1986
• Lethal Hyperkalemia Associated With Severe Hyperglycemia in Diabetic Patients With Renal Failure
  American Journal of Kidney Diseases, 1985